Status:
COMPLETED
Glucose Monitoring During Chemotherapy
Lead Sponsor:
Columbia University
Conditions:
Breast Cancer
Hyperglycemia
Eligibility:
All Genders
18+ years
Brief Summary
This is a research study to look at blood sugar changes during chemotherapy using a continuous blood sugar monitoring device. The device uses patches that attach to the skin on the back of the arm to ...
Detailed Description
This is a prospective observational cohort study monitoring trends in glucose in patients with early stage breast cancer treated with neoadjuvant or adjuvant chemotherapy. Patients will wear a noninva...
Eligibility Criteria
Inclusion
- Age ≥18 years
- History of stage I-III breast cancer
- Patient scheduled to receive adjuvant or neoadjuvant chemotherapy
- Signed informed consent
Exclusion
- Current treatment with insulin
- Current treatment with non-topical steroids, with the exception of steroid treatment as a supportive chemotherapy medication
- Inability to provide informed consent
Key Trial Info
Start Date :
October 31 2019
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
August 17 2022
Estimated Enrollment :
22 Patients enrolled
Trial Details
Trial ID
NCT04473378
Start Date
October 31 2019
End Date
August 17 2022
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Herbert Irving Pavilion
New York, New York, United States, 10032